Global Information Lookup Global Information

Olesoxime information


Olesoxime
Identifiers
IUPAC name
  • (NZ)-N-[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ylidene]hydroxylamine
CAS Number
  • 22033-87-0
PubChem CID
  • 21763506
ChemSpider
  • 23350363
UNII
  • A6778U5IFY
KEGG
  • D11213
CompTox Dashboard (EPA)
  • DTXSID001029582 Edit this at Wikidata
Chemical and physical data
FormulaC27H45NO
Molar mass399.663 g·mol−1
3D model (JSmol)
  • Interactive image
SMILES
  • C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=C/C(=N\O)/CC[C@]34C)C
InChI
  • InChI=1S/C27H45NO/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28-29)13-15-26(20,4)25(22)14-16-27(23,24)5/h17-19,22-25,29H,6-16H2,1-5H3/t19-,22+,23-,24+,25+,26+,27-/m1/s1
  • Key:QNTASHOAVRSLMD-GYKMGIIDSA-N

Olesoxime (TRO19622) is an experimental drug formerly under development by the now-defunct French company Trophos as a treatment for a range of neuromuscular disorders. It has a cholesterol-like structure and belongs to the cholesterol-oxime family of mitochondrial pore modulators.[1][2]

  1. ^ Martin LJ (August 2010). "Olesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosis". IDrugs. 13 (8): 568–580. PMC 3058503. PMID 20721828.
  2. ^ "Olesoxime". New Drugs Online Report. UK Medicines Information. Archived from the original on 2016-03-03.

and 13 Related for: Olesoxime information

Request time (Page generated in 0.5427 seconds.)

Olesoxime

Last Update:

Olesoxime (TRO19622) is an experimental drug formerly under development by the now-defunct French company Trophos as a treatment for a range of neuromuscular...

Word Count : 689

Roche

Last Update:

deal will centre on the Phase II and III spinal muscular atrophy drug olesoxime (TRO19622). In April 2015, Roche acquired CAPP Medical, and its chief...

Word Count : 5233

Diazepam

Last Update:

binding inhibitor (DBI) DPA-713 DPA-714 Emapunil Etifoxine FGIN-1-27 FGIN-1-43 GML-1 Olesoxime Ro5-4864 SSR-180,575 W-18 YL-IPA08 Antagonists PK-11195...

Word Count : 9994

Dithranol

Last Update:

binding inhibitor (DBI) DPA-713 DPA-714 Emapunil Etifoxine FGIN-1-27 FGIN-1-43 GML-1 Olesoxime Ro5-4864 SSR-180,575 W-18 YL-IPA08 Antagonists PK-11195...

Word Count : 474

Etifoxine

Last Update:

binding inhibitor (DBI) DPA-713 DPA-714 Emapunil Etifoxine FGIN-1-27 FGIN-1-43 GML-1 Olesoxime Ro5-4864 SSR-180,575 W-18 YL-IPA08 Antagonists PK-11195...

Word Count : 3481

Trophos

Last Update:

entrepreneurs: Antoine Beret and Michel Delaage. Trophos' lead compound was olesoxime (TRO19622), a mitochondrial targeted compound developed to treat neurodegenerative...

Word Count : 448

Spinal muscular atrophy

Last Update:

enabling the survival of motor neurons even with low levels of SMN protein. Olesoxime was a proprietary neuroprotective compound developed by the French company...

Word Count : 9953

Translocator protein

Last Update:

etifoxine DPA-713 DPA-714 Emapunil Etifoxine FGIN-127 FGIN-143 GML-1 Olesoxime (TRO19622) SSR-180,575 PK-11195 - potent and selective antagonist for...

Word Count : 3181

Alpidem

Last Update:

binding inhibitor (DBI) DPA-713 DPA-714 Emapunil Etifoxine FGIN-1-27 FGIN-1-43 GML-1 Olesoxime Ro5-4864 SSR-180,575 W-18 YL-IPA08 Antagonists PK-11195...

Word Count : 4669

Deuterated etifoxine

Last Update:

binding inhibitor (DBI) DPA-713 DPA-714 Emapunil Etifoxine FGIN-1-27 FGIN-1-43 GML-1 Olesoxime Ro5-4864 SSR-180,575 W-18 YL-IPA08 Antagonists PK-11195...

Word Count : 537

Emapunil

Last Update:

binding inhibitor (DBI) DPA-713 DPA-714 Emapunil Etifoxine FGIN-1-27 FGIN-1-43 GML-1 Olesoxime Ro5-4864 SSR-180,575 W-18 YL-IPA08 Antagonists PK-11195...

Word Count : 659

Diazepam binding inhibitor

Last Update:

binding inhibitor (DBI) DPA-713 DPA-714 Emapunil Etifoxine FGIN-1-27 FGIN-1-43 GML-1 Olesoxime Ro5-4864 SSR-180,575 W-18 YL-IPA08 Antagonists PK-11195...

Word Count : 970

Amyotrophic lateral sclerosis research

Last Update:

mitochondria function (creatine, acetyl-L-carnitine, dexpramipexole, and olesoxime). Other drugs with a variety of mechanisms were tested in clinical trials...

Word Count : 2288

PDF Search Engine © AllGlobal.net